ArchivesMagazine - 03 Jun 2021Why GlaxoSmithKline could bid for Astra's vaccine Glaxo’s response to Covid has been one of the broadest in the industry with two potential treatments as well as multiple vaccine candidates 03 June 2021|Feature Issue: 03 Jun 2021 - Page 17 < Hill & Smith posts faster growth and confirms full year view The price is right: 5 stocks which could win big > Issue: 03 Jun 2021 - Page 17 | Contents Next: The price is right: 5 stocks which could win big Previous: Hill & Smith posts faster growth and confirms full year view Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Martin Gamble Issue Contents Ask Tom Can I recycle tax-free pension withdrawals into a SIPP? Editor's View The clues in everyday life that give you an investing edge Education How to buy foreign shares and the key details you need Feature Why GlaxoSmithKline could bid for Astra's vaccine The price is right: 5 stocks which could win big Funds Some of the best funds come in small packages Managers vs machines - are active funds worth the extra cost? Great Ideas SSE is a great way to play the green revolution Flood of takeover bids boosts Odyssean Buy increasingly profitable safety and compliance firm Marlowe Hill & Smith posts faster growth and confirms full year view Major share overhang finally removed from Brunner Investment Trusts Flexible investment trusts can protect you against inflation News Spiralling housing demand causes price spikes in building materials Gold tops $1,900 again as it regains its haven credentials Competitive pressures face new listing Made.com Aveva eyes renewables as part of its digitisation growth strategy